The future of EGF research holds promising potential. Advances in molecular biology and biotechnology may lead to the development of more efficient EGF-based therapies. Understanding the intricate details of EGF signaling pathways could unveil new therapeutic targets for diseases characterized by aberrant cell proliferation. Moreover, the integration of EGF in personalized medicine could enhance the efficacy of treatments tailored to individual genetic profiles.
